Why it was recalled
Failed Dissolution Specifications
Product description
Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34
Lot numbers, UPCs & expiration codes
Lot AV5913C, Expiry: 6/2027
Where it was sold
US Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0746-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Aug 4, 2026
- FDA report date
- Aug 19, 2026
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Novartis Pharmaceuticals Corporation
Original FDA data
Every field from FDA enforcement report D-0746-2026, exactly as published.
Show all FDA fields
- City
- East Hanover
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 99552
- Address
- 1 Health Plz
- Code information
- Lot AV5913C, Expiry: 6/2027
- Postal code
- 07936-1016
- Report date
- Aug 19, 2026
- Product type
- Drugs
- Recall number
- D-0746-2026
- Classification
- Class II
- Recalling firm
- Novartis Pharmaceuticals Corporation
- Reason for recall
- Failed Dissolution Specifications
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34
- Distribution pattern
- US Nationwide
- Recall initiation date
- Aug 4, 2026
- Initial firm notification
- Letter
- Center classification date
- Aug 7, 2026